Pfizer withdraw valdecoxib (Bextra) at Health Canada's request
نویسندگان
چکیده
منابع مشابه
A request for hospice admission from hospital to withdraw ventilation.
A request to admit a hospital inpatient with motor neurone disease to the hospice generated unusual unease. Significantly, withdrawal of ventilation had already been planned. The presumption that ventilation would be withdrawn after transfer presented a dilemma. Should the hospice accept the admission? If so, should the hospice staff stop the ventilation, and then when and how? Debate centred o...
متن کاملTeaching Note - Assigning Regions to Sales Representatives at Pfizer Turkey
Note: The information regarding the pharmaceutical sector and the company are accurate as collected from various cited sources. The problem contains all the characteristics of the underlying problem faced by Pfizer. It has been simplified for the purpose of keeping the model size manageable as a case study and the data has been altered for reasons of confidentiality. The authors created the cas...
متن کاملThe Pfizer Foundation's Community Health Ventures program: providing models for community health partnerships.
In response to its concern for the future of community health centers (CHCs) and those who receive care in these centers, in 1997 the Pfizer Foundation created and funded Community Health Ventures (CHV), a four-year, $3.6 million grant-making program. It was designed to increase the capacity of centers to adjust to a changing health care environment. This descriptive special report discusses th...
متن کاملNSAID Usage: Impact of Safety Data and Product Withdrawals on Prescribing Trends
the most commonly used classes of medications, accounting for 3% of all prescriptions dispensed in the U.S. About 50 million Americans receive NSAID therapy for both chronic disorders, including rheumatoid arthritis and osteoarthritis, and acute conditions such as postoperative pain, headache, tendonitis or bursitis, and dysmenorrhea. All NSAIDs inhibit the COX enzymes responsible for prostagla...
متن کاملPerspectives. The bad news: unless medical practice is reengineered, I.T. won't help.
The Food and Drug Administration said April 7 it had requested that Pfizer Inc. voluntarily withdraw its painkiller Bextra from the market, and that the drugmaker had agreed to suspend sales and marketing of the so-called Cox-2 inhibitor in the United States “pending further discussions with FDA officials.” The agency also called on the manufacturers of 19 other prescription “non-steroidal anti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Medical Association Journal
سال: 2005
ISSN: 0820-3946,1488-2329
DOI: 10.1503/cmaj.050419